Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma

被引:122
作者
Khoor, A
Whitsett, JA
Stahlman, MT
Olson, SJ
Cagle, PT
机构
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Pathol, Tampa, FL 33612 USA
[2] Childrens Hosp, Cincinnati, OH 45229 USA
[3] Vanderbilt Univ, Ctr Med, Nashville, TN 37232 USA
[4] Baylor Coll Med, Houston, TX 77030 USA
关键词
lung; adenocarcinoma; malignant mesothelioma; pro-SP-B; TTF-1;
D O I
10.1016/S0046-8177(99)90096-5
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Differentiation of malignant mesothelioma from adenocarcinoma, particularly from a lung primary, remains a difficult diagnostic problem. Surfactant protein B precursor (pro-SP-B) and thyroid transcription factor 1 (TTF-1) are expressed selectively in the normal respiratory epithelium and in adenocarcinomas of the lung. In this study, we evaluated the utility of pro-SP-B and TTF-1 in distinguishing pulmonary adenocarcinomas and malignant mesotheliomas. Immunoreactivity for pro-SP-B and TTF-1 was examined in paraffin sections of 370 primary hmg carcinomas (208 adenocarcinomas, 101 squamous cell carcinomas, and 61 large cell carcinomas) and 95 malignant mesotheliomas, using a pro-SP-B antiserum and a monoclonal TTF-1 antibody with a biotin-streptavidin detection system. Immunostaining for pro-SP-B was detected in 57% of adenocarcinomas, and 20% of large cell carcinomas. Immunoreactivity for TTF-1 was shown in 76% of adenocarcinomas and 26% of large cell carcinomas. Malignant mesotheliomas and squamous cell carcinomas did not stain with either antibody. The expression of pro-SP-B and TTF-1 in adenocarcinomas of the lung but not in malignant mesotheliomas shows that pro-SP-B and TTF-I staining is useful in differentiating these neoplasms. Copyright (C) 1999 by W.B. Saunders Company.
引用
收藏
页码:695 / 700
页数:6
相关论文
共 40 条
[1]   MALIGNANT MESOTHELIOMA OF THE PLEURA - INTEROBSERVER VARIABILITY [J].
ANDRION, A ;
MAGNANI, C ;
BETTA, PG ;
DONNA, A ;
MOLLO, F ;
SCELSI, M ;
BERNARDI, P ;
BOTTA, M ;
TERRACINI, B .
JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (09) :856-860
[2]  
[Anonymous], 1982, AM J CLIN PATHOL, V77, P123
[3]  
Bejarano PA, 1996, MODERN PATHOL, V9, P445
[4]   THE LUNG-SPECIFIC SURFACTANT PROTEIN-B GENE PROMOTER IS A TARGET FOR THYROID TRANSCRIPTION FACTOR-1 AND HEPATOCYTE NUCLEAR FACTOR-3, INDICATING COMMON FACTORS FOR ORGAN-SPECIFIC GENE-EXPRESSION ALONG THE FOREGUT AXIS [J].
BOHINSKI, RJ ;
DILAURO, R ;
WHITSETT, JA .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (09) :5671-5681
[5]  
BROERS JLV, 1992, LAB INVEST, V66, P337
[6]   LUNG CELL-SPECIFIC EXPRESSION OF THE MURINE SURFACTANT PROTEIN-A (SP-A) GENE IS MEDIATED BY INTERACTIONS BETWEEN THE SP-A PROMOTER AND THYROID TRANSCRIPTION FACTOR-I [J].
BRUNO, MD ;
BOHINSKI, RJ ;
HUELSMAN, KM ;
WHITSETT, JA ;
KORFHAGEN, TR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (12) :6531-6536
[7]  
CAGLE PT, 1993, MODERN PATHOL, V6, P438
[8]   TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung [J].
Di Loreto, C ;
Puglisi, F ;
Di Lauro, V ;
Damante, G ;
Beltrami, CA .
CANCER LETTERS, 1998, 124 (01) :73-78
[9]  
ELSTON RC, 1987, ESENTIALS BIOSTATIST
[10]  
GAZDAR AF, 1990, CANCER RES, V50, P5481